Who owns CHINA SXT PHARMACEUTICALS IN?
- Ticker: SXTC
- CUSIP Number: g2161p140
Tip: Access positions for across all investors
Analyze quarterly positions in China Sxt Pharmaceuticals In with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of China Sxt Pharmaceuticals In stock
Who bought or sold CHINA SXT PHARMACEUTICALS IN this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Baader Bank | 15k | $7.9k | 100% | Sep 2024 |
|
| GSA Capital Partners | 12k | $9.0k | 100% | Sep 2024 |
|
| Acadian Asset Management | 379.00 | $0 | -86% | Sep 2024 |
|
| Jpmorgan Chase & Co | 376.00 | $273.991200 | 100% | Sep 2024 |
|
| Qube Research & Technologies | 303.00 | $326.755200 | 194% | Jun 2024 |
|
| Banque Cantonale Vaudoise | 1.00 | $0 | 0% | Sep 2024 |
|
Who sold out of China Sxt Pharmaceuticals In?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Virtu Financial | Jun 2024 | 32k | $34k |
| Citadel Advisors | Jun 2024 | 16k | $17k |